UK markets close in 4 hours 24 minutes

Revance Therapeutics, Inc. (RVNC)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.8400-0.0500 (-1.73%)
At close: 04:00PM EDT
2.8508 +0.01 (+0.38%)
After hours: 07:13PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
137,329
108,965
110,623
333,558
-
Other short-term investments
116,586
231,742
114,448
102,947
-
Total cash
253,915
340,707
225,071
436,505
-
Net receivables
27,676
11,339
3,348
1,829
-
Inventory
45,579
18,325
10,154
5,876
-
Other current assets
11,145
4,356
7,544
5,793
-
Total current assets
338,865
374,727
246,117
450,003
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
90,207
59,415
92,330
66,622
-
Accumulated depreciation
-
-28,592
-23,329
-19,491
-16,866
Net property, plant and equipment
90,207
59,415
69,001
47,131
-
Goodwill
0
77,175
146,964
146,964
-
Intangible assets
9,808
35,344
55,334
71,343
-
Other long-term assets
7,191
7,739
6,047
4,779
-
Total non-current assets
139,589
207,173
285,046
270,217
-
Total assets
478,454
581,900
531,163
720,220
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
2,500
-
-
-
-
Accounts payable
13,809
4,546
10,603
12,657
-
Accrued liabilities
19,508
28,030
15,355
14,092
-
Deferred revenues
10,737
6,867
9,362
7,851
-
Other current liabilities
3,184
3,313
4,462
4,553
-
Total current liabilities
89,224
75,682
67,289
60,964
-
Non-current liabilities
Long-term debt
426,595
379,374
280,635
180,526
-
Deferred revenues
70,419
78,577
74,152
77,294
-
Other long-term liabilities
2,835
1,485
1,485
-
-
Total non-current liabilities
540,834
493,618
395,403
284,966
-
Total liabilities
630,058
569,300
462,692
345,930
-
Stockholders' equity
Common stock
88
82
72
69
-
Retained earnings
-2,078,360
-1,754,374
-1,397,952
-1,126,293
-
Accumulated other comprehensive income
14
-374
-18
0
-
Total stockholders' equity
-151,604
12,600
68,471
374,290
-
Total liabilities and stockholders' equity
478,454
581,900
531,163
720,220
-